amphetamine has been researched along with Acute Coronary Syndrome in 5 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
Excerpt | Relevance | Reference |
---|---|---|
"To identify all reported cases of acute coronary syndrome related to the use of amfetamines and cathinones, the type of acute coronary syndrome, the atherothrombotic aetiology, and the mortality rate." | 9.41 | The association of amfetamines and cathinones with acute coronary syndrome - a systematic review. ( de Lange, DW; den Haan, C; Franssen, EJF; Gresnigt, FMJ; Riezebos, RK; Smits, ES, 2023) |
"To identify all reported cases of acute coronary syndrome related to the use of amfetamines and cathinones, the type of acute coronary syndrome, the atherothrombotic aetiology, and the mortality rate." | 5.41 | The association of amfetamines and cathinones with acute coronary syndrome - a systematic review. ( de Lange, DW; den Haan, C; Franssen, EJF; Gresnigt, FMJ; Riezebos, RK; Smits, ES, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Gresnigt, FMJ | 1 |
Smits, ES | 1 |
den Haan, C | 1 |
Riezebos, RK | 1 |
Franssen, EJF | 1 |
de Lange, DW | 1 |
Ali, WM | 1 |
Al Habib, KF | 1 |
Al-Motarreb, A | 1 |
Singh, R | 1 |
Hersi, A | 1 |
Al Faleh, H | 1 |
Asaad, N | 1 |
Al Saif, S | 1 |
Almahmeed, W | 1 |
Sulaiman, K | 1 |
Amin, H | 1 |
Al-Lawati, J | 1 |
Al Bustani, N | 1 |
Al-Sagheer, NQ | 1 |
Al-Qahtani, A | 1 |
Al Suwaidi, J | 1 |
Burillo-Putze, G | 1 |
Dominguez-Rodriguez, A | 1 |
Nogué-Xarau, S | 1 |
Aleryani, SL | 1 |
Al-Akwa, A | 1 |
Nagelkerke, N | 1 |
Conca, W | 1 |
1 review available for amphetamine and Acute Coronary Syndrome
Article | Year |
---|---|
The association of amfetamines and cathinones with acute coronary syndrome - a systematic review.
Topics: Acute Coronary Syndrome; Adult; Amphetamine; Central Nervous System Stimulants; Humans; Male; Metham | 2023 |
4 other studies available for amphetamine and Acute Coronary Syndrome
Article | Year |
---|---|
Acute coronary syndrome and khat herbal amphetamine use: an observational report.
Topics: Acute Coronary Syndrome; Adult; Aged; Amphetamine; Catha; Female; Heart Failure; Humans; Incidence; | 2011 |
Letter by Burillo-Putze et al regarding article, "acute coronary syndrome and khat herbal amphetamine use: an observational report".
Topics: Acute Coronary Syndrome; Amphetamine; Catha; Female; Humans; Male; Plant Preparations | 2012 |
Letter by Aleryani and Al-Akwa regarding article, "Acute coronary syndrome and khat herbal amphetamine use: an observational report".
Topics: Acute Coronary Syndrome; Amphetamine; Catha; Female; Humans; Male; Plant Preparations | 2012 |
Letter by Nagelkerke and Conca regarding article, "acute coronary syndrome and khat herbal amphetamine use: an observational report".
Topics: Acute Coronary Syndrome; Amphetamine; Catha; Female; Humans; Male; Plant Preparations | 2012 |